Focus: Twist Bioscience is a synthetic biology company specializing in synthetic DNA, genes, and gene libraries with applications across neurology, ophthalmology, oncology, gastroenterology, and gene therapy. The company operates as a biotech platform provider enabling therapeutic development across multiple disease areas.
Profile data last refreshed 8h ago · AI intelligence enriched 1w ago
Hot — 42 jobs added in 30d
Net +30 (42 new, 12 removed). Aggressive expansion phase.
Best fit for scientists and commercial professionals seeking platform-company stability with synthetic biology exposure, but not ideal for those prioritizing clinical trial involvement or traditional drug development career arcs.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Twist Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Twist Bioscience's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub